On May 7, 2024 AstraZeneca withdraw their COVID-19 vaccine from the worldwide market, claiming purely commercial reasons even though in a class action against them they admitted their vaccine “can, in very rare cases, cause TTS” (Thrombosis with Thrombocytopenia Syndrome) [1]
